marijuana stocks news

SinglePoint, Inc. (SING)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue (869) 385   275   263  
Cost of Revenue (390) 393 2 2
Gross Profit (479) (8) 274   262  
Operating Expenses
Research Development
Selling General and Administrative (398) 135 1,158 379
Non Recurring 162
Others
Total Operating Expenses
Operating Income or Loss (243) (143) (884) (117)
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes (243) (143) (884) (117)
Interest Expense 33 13 13 13
Income Before Tax (276) (156) (897) (130)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (276) (156) (897) (130)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (270) (156) (897) (130)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (270) (156) (897) (130)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Verano Holdings Corp. (VRNOF) Announces the Opening of MÜV Navarre, the Company’s 63rd Florida Location

Verano Announces the Opening of MÜV Navarre, the Company’s 63rd Florida Location…

Cresco Labs Inc. (CRLBF) to Operate Kentucky’s Largest Medical Cannabis Cultivation License

Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License Cresco Labs…

InMed Pharmaceuticals (IMLFF) (IN) Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer

VANCOUVER, Jan. 11, 2019 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the…